Abstract
The crucial role of costimulatory molecules, CD28, CTLA-4, CD80 and CD86, for T cell activation and inhibition has been established. In the previous study, we reported the results of a polymorphism screening of human CTLA-4 gene. In this study, we screened for polymorphisms of human CD28, CD80 and CD86 genes, and detected that polymorphisms were tested for the association with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Variations were identified in the coding regions of CD80 (452G/A, 614C/G and 864A/G) and CD86 (1057A/G), while no variation was observed in the coding region of CD28. The variations at CD80 position 452 and CD86 position 1057 were present in a substantial proportion of the Japanese population, and were considered to be single nucleotide polymorphisms within the coding sequence (cSNPs). CD80 864 (G→A) leads to the amino acid substitution N186D, and CD86 1057 (A→G) results in A304T substitution. Furthermore, in the analysis of CD80 5′-flanking region, six SNPs, −454C/A, −387T/C, −232G/A, −79G/C, −7T/C and +5C/A, and one insertion, −558ins (CATGA), were identified. The combination of these variations was found to constitute four promoter alleles of CD80. None of the observed variations was significantly associated with RA or SLE. Further studies will be of particular interest to examine the functional difference of the promoter alleles for the transcriptional activity of CD80, as well as the evolutionary pathway of the four alleles.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by a Grant-in Aid for Scientific Research (B) (11470505) from the Ministry of Education, Science, Sports and Culture. The nucleotide sequence data reported in this paper will appear in the DDBJ/EMBL/GenBank nucleotide sequence databases with the accession numbers AB033124, AB033125, AB033126 and AB033127.
Rights and permissions
About this article
Cite this article
Matsushita, M., Tsuchiya, N., Oka, T. et al. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun 1, 428–434 (2000). https://doi.org/10.1038/sj.gene.6363704
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363704
Keywords
This article is cited by
-
Impact of CD 28, CD86, CTLA-4 and PD-1 genes polymorphisms on acute renal allograft rejection and graft survival among Egyptian recipients
Scientific Reports (2024)
-
Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective
Immunogenetics (2019)
-
CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis—results and the review of the literature
Clinical Rheumatology (2011)
-
CD86 Gene polymorphisms: no association with Type I diabetes among Finnish subjects
Diabetologia (2002)